GO Term |
---|
mitogen-activated protein kinase binding |
metallodipeptidase activity |
peptidase activity |
heterocyclic compound binding |
chloride ion binding |
mitogen-activated protein kinase kinase binding |
bradykinin receptor binding |
Position | Description |
---|---|
523 | Not glycosylated |
1225 | Not glycosylated |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
38 | N-linked (GlcNAc...) asparagine |
|
||
54 | N-linked (GlcNAc...) asparagine |
|
||
74 | N-linked (GlcNAc...) asparagine |
|
||
103 | N-linked (GlcNAc...) asparagine |
|
||
111 | N-linked (GlcNAc...) asparagine |
|
||
121 | N-linked (GlcNAc...) asparagine |
|
||
140 | N-linked (GlcNAc...) asparagine |
|
||
146 | N-linked (GlcNAc...) asparagine | |||
160 | N-linked (GlcNAc...) asparagine |
|
||
318 | N-linked (GlcNAc...) asparagine |
|
Pathway Name | Organism |
---|---|
Metabolism of Angiotensinogen to Angiotensins | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110197 | Charcot-Marie-Tooth disease dominant intermediate B | |
DOID:0110198 | Charcot-Marie-Tooth disease recessive intermediate C | |
DOID:0110199 | Charcot-Marie-Tooth disease dominant intermediate C | |
DOID:0110200 | Charcot-Marie-Tooth disease dominant intermediate D | |
DOID:0110202 | Charcot-Marie-Tooth disease dominant intermediate A | |
DOID:0110203 | Charcot-Marie-Tooth disease recessive intermediate D | |
DOID:0110204 | Charcot-Marie-Tooth disease recessive intermediate B | |
DOID:0110205 | Charcot-Marie-Tooth disease dominant intermediate E | |
DOID:419 | scleroderma | |
DOID:0110206 | Charcot-Marie-Tooth disease dominant intermediate F |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024